In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens
Authors
Keywords
NCL195, Colistin, Gram-negative bacteria, Multidrug resistance, Transmission electron microscopy, Synergy
Journal
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 57, Issue 5, Pages 106323
Publisher
Elsevier BV
Online
2021-03-20
DOI
10.1016/j.ijantimicag.2021.106323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates
- (2021) Julalak C. Ontong et al. PLoS One
- A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
- (2020) Meirong Song et al. Nature Microbiology
- In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice
- (2020) Hongfei Pi et al. Frontiers in Microbiology
- The Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility?
- (2019) George H Talbot et al. CLINICAL INFECTIOUS DISEASES
- The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program
- (2019) Daniel J. Diekema et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Developments on antibiotics for multidrug resistant bacterial Gram-negative infections
- (2019) Georgios L. Voulgaris et al. Expert Review of Anti-Infective Therapy
- In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens
- (2019) Manouchehr Khazandi et al. Frontiers in Microbiology
- Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections
- (2019) Adam G Stewart et al. CLINICAL INFECTIOUS DISEASES
- Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae
- (2018) Thea Brennan-Krohn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic–non-antibiotic combinations for combating extremely drug-resistant Gram-negative ‘superbugs’
- (2017) Elena K. Schneider et al. Essays in Biochemistry
- Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria
- (2017) Mohsen Arzanlou et al. Essays in Biochemistry
- The drug-resistant bacteria that pose the greatest health threats
- (2017) Cassandra Willyard NATURE
- Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent
- (2017) Abiodun D. Ogunniyi et al. PLoS One
- Treatment of Gram-negative bacterial infections by potentiation of antibiotics
- (2016) Thomas P Zabawa et al. CURRENT OPINION IN MICROBIOLOGY
- Molecular mechanisms of polymyxin resistance: knowns and unknowns
- (2016) Sophie Baron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Synergistic combinations of polymyxins
- (2016) Justin R. Lenhard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Robenidine Analogues as Gram-Positive Antibacterial Agents
- (2016) Rebecca J. Abraham et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polymyxin Combinations: Pharmacokinetics and Pharmacodynamics for Rationale Use
- (2015) Phillip J. Bergen et al. PHARMACOTHERAPY
- Is transmission electron microscopy (TEM) a promising approach for qualitative and quantitative investigations of polymyxin B and miconazole interactions with cellular and subcellular structures of Staphylococcus pseudintermedius , Escherichia coli , Pseudomonas aeruginosa and Malassezia pachydermatis ?
- (2015) Michael Voget et al. VETERINARY MICROBIOLOGY
- Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
- (2015) Helen I. Zgurskaya et al. ACS Infectious Diseases
- Approval and Withdrawal of New Antibiotics and other Antiinfectives in the U.S., 1980–2009
- (2015) Kevin Outterson et al. JOURNAL OF LAW MEDICINE & ETHICS
- Antimicrobial mechanism of flavonoids against Escherichia coli ATCC 25922 by model membrane study
- (2014) Mengying He et al. APPLIED SURFACE SCIENCE
- Adverse Reactions Associated with Systemic Polymyxin Therapy
- (2014) Julie Ann Justo et al. PHARMACOTHERAPY
- Synergistic Effect between Colistin and Bacteriocins in Controlling Gram-Negative Pathogens and Their Potential To Reduce Antibiotic Toxicity in Mammalian Epithelial Cells
- (2013) Karim Naghmouchi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens
- (2013) L. Phee et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Clinical relevance of the ESKAPE pathogens
- (2013) Jack N Pendleton et al. Expert Review of Anti-Infective Therapy
- The Target of Daptomycin Is Absent from Escherichia coli and Other Gram-Negative Pathogens
- (2012) Christopher P. Randall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
- (2010) A. Elemam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement
- (2008) Ian Chopra et al. LANCET INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started